Information technologyInvestors see Biogen CEO choice as friendly to potential takeover | Reuters
The surprise selection of Michel Vounatsos to run Biogen Inc signals a shift toward a more commercial management focus after years of targeting ambitious scientific gains, and likely keeps the U.S. biotech in play as a takeover target.
PharmaceuticalsIs Trump the first crack in the drug industry's right flank? | STAT
Donald Trump is unorthodox, to say the least, when it comes to his opinions about the drug industry. Trump's ascent is now generating whispers at the highest levels of industry about whether the Republican Party will remain a bedrock of support. Is Trump an aberration — or is he a sign of things to come?
Aging and addicted: the opioid epidemic affects older adults, too | Kaiser Health News
As the nation grapples with a devastating opioid epidemic, concerns have primarily focused on young people buying drugs on the street. But America's elderly also have a problem.
New York City is about to reach a milestone in drug overdoses. By the end of 2016, it's expected that more than 1,000 people will have died of overdoses. One reason for the spike: the drug fentanyl.